HIPEC: Clinical Trials

10 trials for HIPEC, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 active not recruiting, 2 not yet recruiting, 2 recruiting. 2 Not applicable, 2 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Not yet recruiting 1
Phase 22Not yet recruiting 1, Terminated 1
Phase 11Completed 1
Phase 31Active not recruiting 1

Follow HIPEC: new trials by email Literature Review of HIPEC trials Research Report on HIPEC

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Impact of an Omega-3 Enriched Oral Nutritional Supplement on Improving Surgical Outcomes in Patients With Peritoneal Carcinomatosis Undergoing Cytoreductive Surgery
ONS enriched with Omega-3, Standard ONS - Peritoneal Carcinosis, Peritoneal Metastases
Not applicableNot yet recruitingCatholic University of the Sacred Heart282026-04-012026-03-17
Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Cancer
curative-intent surgery + HIPEC - Gastric Cancer (GC), HIPEC
RecruitingUkrainian Society of Clinical Oncology2002025-12-012026-01-13
Evaluating the Efficacy of Hyperthermic Intraperitoneal Treatment to Enhance the Sensitivity of Immune Checkpoint Inhibitor in Patients With Advanced Ovarian Cancer: A Single-arm Study
ICI-HIPET - HIPEC, Ovarian Serous Adenocarcinoma
Phase 2Not yet recruitingJing Li302025-08-012025-07-16
Effects of HIPEC on Postoperative Bowel Motility and Complications
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) - HIPEC, Gastro Intestinal Cancer
Active not recruitingPeking University People's Hospital1932025-04-202026-01-20
Thermodynamic Model of Hyperthermia in Humans Undergoing HIPEC
Additional temperature monitoring/recording - HIPEC
RecruitingHenry Ford Health System302022-09-222025-10-20
CRS & HIPEC for Platinum-Resistant Recurrent Ovarian Cancer (KOV-02R, RECOVER)
HIPEC - Epithelial Ovarian Cancer, Platinum Resistant
Phase 3Active not recruitingNational Cancer Center, Korea1402022-04-072026-02-12
Raltitrexed in HIPEC
Raltitrexed - Colorectal Cancer, Raltitrexed
Phase 1CompletedFudan University302020-09-182026-02-25
Cytoreductive Surgery and Intraperitoneal Chemotherapy for Stomach CAncer: a Feasibility Study
Perioperative chemotherapy, Cytoreduction, HIPEC - Gastric Cancer, Peritoneal Carcinomatosis
Phase 2TerminatedRichard van Hillegersberg32017-08-012019-04-17
Are You in a Poor Country; HIPEC is Still in Reach
HIPEC device - HIPEC
Not applicableCompletedZagazig University502014-01-012020-12-11
HIPEC in Ovarian Cancer, Case-Controls Study With 10-years Follow up
cytoreduction and HIPEC - Ovarian Cancer, HIPEC
CompletedInstituto de Seguridad Social del Estado de Mexico y Municipios1442007-08-012020-01-29

Narrower conditions

Ovarian Neoplasms (2)  ·  Stomach Neoplasms (2)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Colorectal Neoplasms (1)  ·  Digestive System Neoplasms (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Neoplasms (1)  ·  Peritoneal Neoplasms (1)  ·  Stomach Diseases (1)

Broader conditions

Neoplasms (5)  ·  Neoplasms by Site (5)  ·  Digestive System Diseases (3)  ·  Adnexal Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Endocrine Gland Neoplasms (2)  ·  Endocrine System Diseases (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Gastrointestinal Diseases (2)  ·  Gastrointestinal Neoplasms (2)  ·  Genital Diseases (2)  ·  Genital Diseases, Female (2)  ·  Genital Neoplasms, Female (2)  ·  Gonadal Disorders (2)

Interventions

Hyperthermic Intraperitoneal Chemotherapy (6)  ·  Cytoreduction Surgical Procedures (2)  ·  Docosahexaenoic Acids (1)  ·  raltitrexed (1)

Sponsors

Catholic University of the Sacred Heart (1)  ·  Fudan University (1)  ·  Henry Ford Health System (1)  ·  Instituto de Seguridad Social del Estado de Mexico y Municipios (1)  ·  Jing Li (1)  ·  National Cancer Center, Korea (1)  ·  Peking University People's Hospital (1)  ·  Richard van Hillegersberg (1)  ·  Ukrainian Society of Clinical Oncology (1)  ·  Zagazig University (1)

Countries

China (3)  ·  Italy (1)  ·  Netherlands (1)  ·  South Korea (1)  ·  Ukraine (1)  ·  United States (1)

Top investigators

Carlos Guerra, MD (1)  ·  Jelle P Ruurda, MD PhD (1)  ·  Richard van Hillegersberg, MD PhD (1)

Results publications

PMID 39955184

NIH funding

2016 (1)